Daxor continues development of BVA-100:
This article was originally published in Clinica
Executive Summary
Daxor (US) is to continue development of its BVA-100 blood volume analyser now that production of its albumin I-131 isotope has been approved by the US FDA. A suspended 510(k) application for the BVA-100 will now continue after eight years waiting for approval of the isotope. Iodine-131 is essential for measuring blood volume and will be part of the test kit for the New York-based company's analyser used during surgery. The albumin I-131 will be manufactured by Texas-based Iso-Tex Diagnostics.